WHO ICTRP trial
AN OPEN-LABEL, EXTENSION SAFETY TRIAL OF PREGABALIN IN SUBJECTS WITH NEUROPATHIC…
PER-001-11 · Registro Peruano de Ensayos Clínicos (REPEC)
Key facts
| Trial ID | PER-001-11 |
|---|---|
| Public title | AN OPEN-LABEL, EXTENSION SAFETY TRIAL OF PREGABALIN IN SUBJECTS WITH NEUROPATHIC PAIN ASSOCIATED WITH HIV NEUROPATHY (PREGABALIN A0081251) |
| Scientific title | AN OPEN-LABEL, EXTENSION SAFETY TRIAL OF PREGABALIN IN SUBJECTS WITH NEUROPATHIC PAIN ASSOCIATED WITH HIV NEUROPATHY (PREGABALIN A0081251) |
| Primary sponsor | PFIZER S.A., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Study type | Interventional |
| Phase | III |
| Countries | India;Thailand;Puerto Rico;South Africa;Colombia;Peru;United States |
| Interventions | FOLLOWING COMPLETION OF THE A0081244 DOUBLE-BLIND TRIAL, SUBJECTS WHO MEET ALL INCLUSION AND NO EXCLUSION CRITERIA AND HAVE COMPLETED AT LEAST VISIT 9 OF STUDY A0081244 HAVE THE OPTION OF INITIATING TREATMENT WITH PREGABALIN UNDER… |
| Registration date | Feb 21, 2011 |
| Target size | 20 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: